Jan 10 (Reuters) – Kite Pharma Inc said on Tuesday
it had formed a joint venture with Shanghai Fosun Pharmaceutical
(Group) Co Ltd to develop and
commercialize its cancer treatment in China.
The post Kite, Fosun Pharma form JV in China for cancer treatment appeared first on NASDAQ.